CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)
$3.71 -0.1 (-2.6247%)
Analysed CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) News Sources
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates
06-05-2026
yahoo.com
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
07-05-2026
yahoo.com
CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates
07-05-2026
yahoo.com
CytomX Therapeutics Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
CytomX (CTMX) Q1 2026 Earnings Transcript
08-05-2026
fool.com
Earnings Beat: CytomX Therapeutics, Inc. (NASDAQ:CTMX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
11-05-2026
yahoo.com
New Forecasts: Here's What Analysts Think The Future Holds For CytomX Therapeutics, Inc. (NASDAQ:CTMX)
13-05-2026
yahoo.com
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
18-05-2026
yahoo.com
CytomX Therapeutics to Present at Upcoming June Investor Conferences
21-05-2026
yahoo.com
How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data And Risks
28-05-2026
yahoo.com
What is the current price of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The current price of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is $3.71.
CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) since the previous trading day is $-0.1.
CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) since the previous trading day is -2.6247%.
What is the most recent average sentiment score for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The most recent average sentiment score for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The most recent sentiment for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is .
SEC-8K** Filing Available For CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.